Repligen (RGEN) Profit After Tax (2010 - 2026)
Repligen (RGEN) posted quarterly Profit After Tax of $5.0 million for Q2 2026, down 91.79% year-over-year from $61.0 million in Q2 2025, and down 39.9% quarter-over-quarter from $8.3 million in Q1 2026.
Repligen (RGEN) Profit After Tax (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Profit After Tax for 17 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Profit After Tax fell 91.79% year-over-year to $5.0 million; the TTM figure through Jun 2026 stood at $43.1 million (up 49.18% YoY), while the FY2025 annual figure was $98.9 million, up 345.77% from the prior year.
- Profit After Tax declined to $5.0 million in Q2 2026 per RGEN's latest filing, from $8.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at $61.0 million in Q2 2025 and bottomed at -$51.8 million in Q4 2024.
- Historically, Profit After Tax has averaged $17.0 million across 5 years, with a median of $14.9 million in 2025.
- Annual changes were most pronounced in 2024 — Profit After Tax sank 214.77% — and 2025, when it soared 967.58%.
- Repligen's Profit After Tax stood at $48.7 million in 2022, then plunged by 133.76% to -$16.4 million in 2023, then tumbled by 214.77% to -$51.8 million in 2024, then soared by 128.7% to $14.9 million in 2025, then plunged by 66.31% to $5.0 million in 2026.
- Business Quant data shows RGEN's Profit After Tax at $5.0 million in Q2 2026, $8.3 million in Q1 2026, and $14.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 451.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 154.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 92.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -107.10 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 5.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.01 Mn |
| Mar 31, 2026 | 8.33 Mn |
| Dec 31, 2025 | 14.86 Mn |
| Sep 30, 2025 | 14.91 Mn |
| Jun 30, 2025 | 60.99 Mn |
| Mar 31, 2025 | 10.52 Mn |
| Dec 31, 2024 | -51.78 Mn |
| Sep 30, 2024 | 9.17 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | -16.45 Mn |
| Sep 30, 2023 | 16.92 Mn |
| Jun 30, 2023 | 19.79 Mn |
| Mar 31, 2023 | 18.32 Mn |
| Dec 31, 2022 | 48.73 Mn |
| Sep 30, 2022 | 40.41 Mn |
| Jun 30, 2022 | 49.86 Mn |
| Mar 31, 2022 | 46.96 Mn |
| Dec 31, 2021 | 29.11 Mn |
| Sep 30, 2021 | 33.50 Mn |